Amplio Spine™ Welcomes Nomen Azeem, MD, as Clinical Leader and Advisor

Amplio Spine™ Welcomes Nomen Azeem, MD, as Chief Clinical Officer and Founding Chair of the Advisory Board

Amplio Spine, a pioneering medical device company specializing in spinal stabilization technologies, has made a significant leadership appointment by welcoming Dr. Nomen Azeem, MD, FAAPMR as its new Chief Clinical Officer and Founding Chair of the Clinical Advisory Board. With over 15 years of experience in interventional spine and pain medicine, Dr. Azeem brings a wealth of knowledge that will bolster the company’s clinical strategies and research initiatives.

As Chief Clinical Officer, Dr. Azeem is tasked with spearheading Amplio’s clinical agenda. His responsibilities will include overseeing clinical outcomes measurement and ensuring that patient-centered care remains at the forefront of the organization's goals. With Dr. Azeem at the helm of Amplio’s clinical strategy, the company aims to create robust frameworks for research programs and clinical governance that encompass neurospine, orthospine, and interventional pain methodologies.

Josh Lambert, the CEO of Amplio Spine, expressed optimism about Dr. Azeem's appointment, highlighting his strategic leadership qualities and extensive understanding of data-driven surgical practices. Lambert stated, "Dr. Azeem’s insights into translating clinical evidence into practice align perfectly with our mission. He possesses the credibility needed to guide KeyLift® to success while maintaining the integrity of clinical implementation."

Dr. Azeem’s distinguished career includes completing a residency in Physical Medicine and Rehabilitation at Georgetown University Hospital, where he was recognized as Chief Resident. He further advanced his expertise by undergoing an ACGME-accredited Interventional Pain Fellowship at Temple University under the mentorship of Dr. Frank Falco. Currently, Dr. Azeem serves as the Program Director for the ACGME-accredited Pain Medicine Fellowship, collaborating with HCA Florida Healthcare and the USF Morsani College of Medicine. As a Principal Investigator for several clinical studies, he has contributed significantly to the field, authoring over 40 publications and book chapters concerning minimally invasive spine procedures and resultant surgical outcomes.

Moreover, Dr. Azeem plays crucial roles as Secretary of the Executive Board at the American Society of Pain Neuroscience and Treasurer of the Global Spine Initiative. His comprehensive approach towards treatment methodologies aligns closely with Amplio’s objective to innovate spinal healthcare effectively.

Commenting on his new role, Dr. Azeem remarked, "I believe KeyLift addresses a critical need in interlaminar stabilization. The mechanism is well-founded, and the anatomy is suitable. My focus will be on rigorous data collection and evaluating clinical outcomes, ensuring that all our decisions prioritize patient benefits."

Amplio Spine is dedicated to developing unique devices that enhance spinal stabilization while promoting supplemental fusion solutions. With its headquarters based in Boca Raton, Florida, the company emphasizes physician partnerships and innovation. Their flagship platform, KeyLift®, has received FDA clearance under 510(k) K232484, and Amplio Spine is committed to evolving its product portfolio to meet the dynamic demands of neurosurgeons, orthopedic spine surgeons, and interventional pain specialists worldwide.

For further updates on Amplio Spine and its groundbreaking endeavors in spinal device technology, visit ampliospine.com.

This landmark appointment reflects Amplio Spine's forward-thinking approach to spinal care, fostering an environment where clinical excellence intertwines with patient-centric healthcare solutions.